A pill for delivering biomedical micromotors

September 05, 2018

Using tiny micromotors to diagnose and treat disease in the human body could soon be a reality. But keeping these devices intact as they travel through the body remains a hurdle. Now in a study appearing in ACS Nano, scientists report that they have found a way to encapsulate micromotors into pills. The pill's coating protects the devices as they traverse the digestive system prior to releasing their drug cargo.

About the width of a human hair, micromotors are self-propelled microscopic robots designed to perform a host of biomedical tasks. In previous research, Joseph Wang, Liangfang Zhang and colleagues used micromotors coated with an antibiotic to treat ulcers in laboratory mice. They found that this approach produced better results than just taking the drugs by themselves. However, the researchers noted that body fluids, such as gastric acid and intestinal fluids, can compromise the effectiveness of micromotors and trigger early release of their payloads. In addition, when taken orally in fluid, some of the micromotors can get trapped in the esophagus. To overcome these issues, Wang and Zhang sought to develop a way to protect and carry these devices into the stomach without compromising their mobility or effectiveness.

The researchers created a pill composed of a pair of sugars -- lactose and maltose -- that encapsulated tens of thousands of micromotors made of a magnesium/titanium dioxide core loaded with a fluorescent dye cargo. These sugars were chosen because they are easy to mold into tablet, can disintegrate when needed and are nontoxic. When given to laboratory mice, these pills improved the release and retention of the micromotors in the stomach compared to those encapsulated in silica-based tablets or in a liquid solution. The researchers concluded that encapsulating micromotors in traditional pill form improves their ability to deliver medicines to specific targets without diminishing their mobility or performance.
-end-
The authors acknowledge funding from the Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense, the Charles Lee Powell Foundation, the Consejo Nacional de Ciencia y Tecnología (CONACyT) postdoctoral fellowship, Fulbright grants, the Comisión Nacional de Investigacion Cientifica y Tecnologica (CONICYT) and the China Scholarship Council.

The American Chemical Society, the world's largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Follow us: Twitter | Facebook

American Chemical Society

Related Human Body Articles from Brightsurf:

Human norovirus strains differ in sensitivity to the body's first line of defense
Human norovirus strains differ in sensitivity to interferon, one of the body's first line of defense.

"Hotspots" of a corona infection in the human body
An infection with the coronavirus SARS-CoV-2 can affect multiple organs.

UTEP researchers develop nanohybrid vehicle to optimally deliver drugs into the human body
The researchers discovered that encapsulating ellagic acid in chitosan, a sugar, reduces its inherent cytotoxicity while enhancing its antioxidant properties.

Protecting thin, flexible brain interfaces from the human body
Researchers have demonstrated the ability to implant an ultrathin, flexible neural interface with thousands of electrodes into the brain with a projected lifetime of more than six years.

The human body as an electrical conductor, a new method of wireless power transfer
The project Electronic AXONs: wireless microstimulators based on electronic rectification of epidermically applied currents (eAXON, 2017-2022), funded by a European Research Council (ERC) Consolidator Grant awarded to Antoni Ivorra, head of the Biomedical Electronics Research Group (BERG) of the Department of Information and Communication Technologies (DTIC) at UPF principally aims to 'develop very thin, flexible, injectable microstimulators to restore movement in paralysis', says Ivorra, principal investigator of the project.

Wake Forest scientists create world's most sophisticated lab model of the human body
Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have developed the world's most sophisticated laboratory model of the human body, creating a system of miniaturized organs that can be used to detect harmful and adverse effects of drugs before they are prescribed to patients.

Enhancing drug testing with human body-on-chip systems
Scientists at Tel Aviv University and Harvard University have devised a functioning comprehensive multi-Organ-on-a-Chip (Organ Chip) platform that enables effective preclinical drug testing of human drug pharmacology.

Human Body-on-Chip platform enables in vitro prediction of drug behaviors in humans
Wyss Institute researchers have created a human Body-on-Chips platform that lays the foundation for better and faster drug testing.

Machine keeps human livers alive for one week outside of the body
Researchers from the University Hospital Zurich, ETH Zurich, Wyss Zurich and the University of Zurich have developed a machine that repairs injured human livers and keeps them alive outside the body for one week.

Developed a band-aid-like sensor to detect human body conditions in real-time
DGIST announced that Professor Hyuk-Jun Kwon in the Department of Information and Communication Engineering developed a 'patch-based health diagnosis sensor system' that is easily attached to skin with Professor Sunkook Kim's research team at Sungkyunkwan University.

Read More: Human Body News and Human Body Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.